Company intelligence / Profile preview

King Fund

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

King Fund appears to be a private investment firm rather than a life sciences operating company. Publicly available information indicates it is active, based in London, England, and has made at least one disclosed investment, including in Huma.AI. There is no clear evidence that King Fund itself develops drugs, diagnostics, medical devices, or healthcare services. As a result, it should not be classified as a biotech, pharma, or healthcare company, although it may invest selectively in health-related businesses.

Industry: Investors

Beyond the preview

Go deeper on King Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on King Fund.

Explore the full profile